PERCUTANEOUS TRANSLUMINAL DILATION IN RENAL TRANSPLANT ARTERIAL STENOSIS

Authors:
  • KSKenneth W. Sniderman
    Kenneth W. Sniderman
  • TSThomas A. Sos
    Thomas A. Sos
  • SSSouheil Saddekni
    Souheil Saddekni
  • SHSusan Hilton
    Susan Hilton
  • FMFred Mollenkopf
    Fred Mollenkopf
  • RSRobert Soberman
    Robert Soberman
  • JCJhoong S. Cheigh
    Jhoong S. Cheigh
  • LTLuis Tapia
    Luis Tapia
  • WSWilliam Stubenbord
    William Stubenbord
  • VTVivian Tellis
    Vivian Tellis
  • FVFrank J. Veith
    Frank J. Veith

Abstract
Twelve hypertensive patients underwent percutaneous transluminal dilation (PTD) for relief of arterial stenosis complicating renal allotransplantation. Two patients underwent repeat PTD for recurrent stenosis and hypertension. Six patients had end to end anastomosis of the donor renal artery to the recipient hypogastric artery; four of six PTDs were successful. Six patients had end to side anastomosis of the donor renal artery to the recipient external iliac artery; seven of eight PTDs, including one of two repeat PTDs, were successful. Prior to PTD, all patients were using several antihypertensive medications. Following successful PTD, the mean blood pressure dropped from 184 +/- 15/118 +/- 9 to 133 +/- 13/89 +/- 11 mm Hg (P < 0.001) and remained at that level for up to 15 months (average followup 9 months) with decreased or no antihypertensive medications. Since surgical correction of arterial stenosis occurring after renal transplantation is difficult and may endanger the graft, PTD should be the first interventional therapy.